Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07292519
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
Sponsor: South West Sydney Local Health District
Interventions
Placebo Take Control CBT Module Tirzepatide
Updated 2 times since 2026 Last updated: Dec 15, 2025 Started: Jan 15, 2026 Primary completion: May 15, 2027 Completion: Jan 15, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07292519, this PHASE2 trial focuses on Alcohol Use Disorder (AUD) and Comorbidities and Coexisting Conditions and remains actively recruiting participants. Sponsored by South West Sydney Local Health District, it has been updated 2 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Mar 2026 — Present [monthly]
Not Yet Recruiting PHASE2
-
Jan 2026 — Mar 2026 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- South West Sydney Local Health District
- University of Sydney
Data source: South West Sydney Local Health District
For direct contact, visit the study record on ClinicalTrials.gov .